European Journal of Heart Failure, 22(11), 2160-2171. Wiley Teerlink, J R, Diaz, R, Felker, G M, McMurray, J J V, Metra, M, Solomon, S D, Adams, K F, Anand, I, Arias-Mendoza, A, Biering-Sorensen, T, Bohm, M, Bonderman, D, Cleland, J G F, Corbalan, R, Crespo-Leiro, M G, Dahlstrom, U, Echeverria Correa, L E, Fang, J C, Filippatos, G, Fonseca, C, Goncalvesova, E, Goudev, A R, Howlett, J G, Lanfear, D E, Lund, M, Macdonald, P, Mareev, V, Momomura, S, O'Meara, E, Parkhomenko, A, Ponikowski, P, Ramires, F J A, Serpytis, P, Sliwa, K, Spinar, J, Suter, T M, Tomcsanyi, J, Vandekerckhove, H, Vinereanu, D, Voors, A A, Yilmaz, M B, Zannad, F, Sharpsten, L, Legg, J C, Abbasi, S A, Varin, C, Malik, F I, Kurtz, C E & GALACTIC HF Investigators 2020, ' Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction : GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials ', European Journal of Heart Failure, vol. 22, no. 11, pp. 2160-2171 . https://doi.org/10.1002/ejhf.2015 Eur J Heart Fail European journal of heart failure, Hoboken : John Wiley and Sons Ltd, 2020, vol. 22, iss. 11, p. 2160-2171 European Journal of Heart Failure European Journal of Heart Failure, 2020, 22 (11), pp.2160-2171. ⟨10.1002/ejhf.2015⟩ RUC: Repositorio da Universidade da Coruña Universidade da Coruña (UDC) RUC. Repositorio da Universidade da Coruña instname